Public-registry site landscape for NCT04946318, a Asthma study sponsored by Novartis Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04946318 (registry record) |
| Sponsor | Novartis Pharmaceuticals |
| Condition(s) | Asthma |
| Phase | PHASE2 |
| Listed sites | 58 |
| Site countries | United States, Argentina, Belgium, Bulgaria, Canada, Czechia, Germany, Hungary, Japan, Latvia, Philippines, Poland |
Eichor generates a preliminary site-risk snapshot for NCT04946318 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →